Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Assets (2020 - 2024)

Historic Assets for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $69.3 billion.

  • Universe Pharmaceuticals' Assets fell 9989.8% to $69.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 billion, marking a year-over-year decrease of 9989.8%. This contributed to the annual value of $69.3 billion for FY2025, which is 9989.8% down from last year.
  • According to the latest figures from Q3 2025, Universe Pharmaceuticals' Assets is $69.3 billion, which was down 9989.8% from $67953.4 billion recorded in Q3 2024.
  • In the past 5 years, Universe Pharmaceuticals' Assets registered a high of $67953.4 billion during Q3 2024, and its lowest value of $41.7 million during Q3 2023.
  • For the 5-year period, Universe Pharmaceuticals' Assets averaged around $8502.9 billion, with its median value being $70.3 million (2021).
  • Per our database at Business Quant, Universe Pharmaceuticals' Assets skyrocketed by 24352182509.6% in 2021 and then plummeted by 9989.8% in 2025.
  • Quarter analysis of 5 years shows Universe Pharmaceuticals' Assets stood at $70.1 million in 2021, then decreased by 15.12% to $59.5 million in 2022, then fell by 29.92% to $41.7 million in 2023, then skyrocketed by 162862060.88% to $67953.4 billion in 2024, then crashed by 99.9% to $69.3 billion in 2025.
  • Its last three reported values are $69.3 billion in Q3 2025, $67953.4 billion for Q3 2024, and $49.4 million during Q1 2024.